Deep Track Capital, LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
69
Total Value
3088173822
Accession Number
0001856083-25-000002
Form Type
13F-HR
Manager Name
Deep Track Capital, LP
Data Enrichment
93% identified
64 identified5 unidentified

Holdings

69 positions
Manager:
Search and click to pin securities to the top
Page 3 of 4
Sage Therapeutics, Inc.
Shares:
2038845
Value:
$16.2B
Terns Pharmaceuticals, Inc.
Shares:
5576558(+0.0%)
Value:
$15.4B(-50.2%)
Korro Bio, Inc.
Shares:
874614(+0.0%)
Value:
$15.2B(-54.3%)
Oruka Therapeutics, Inc.
Shares:
1444709(+92.6%)
Value:
$14.8B(+1.9%)
Mind Medicine (MindMed) Inc.
Shares:
2500000(-11.2%)
Value:
$14.6B(-25.4%)
Upstream Bio, Inc.
Shares:
2299567(+129.9%)
Value:
$14.1B(-14.4%)
Olema Pharmaceuticals, Inc.
Shares:
3442833(+0.0%)
Value:
$12.9B(-35.5%)
Septerna, Inc.
Shares:
1912929(+0.0%)
Value:
$11.1B(-74.7%)
NOVAVAX INC
Shares:
1518182(-24.1%)
Value:
$9.7B(-39.5%)
CYBIN INC.
Shares:
1529987(+0.0%)
Value:
$9.7B(-28.1%)
RAPT Therapeutics, Inc.
Shares:
6011380(+0.0%)
Value:
$7.3B(-22.8%)
PLIANT THERAPEUTICS, INC.
Shares:
5399681(-9.6%)
Value:
$7.3B(-90.7%)
Avalo Therapeutics, Inc.
Shares:
859876(-0.8%)
Value:
$6.9B(+6.9%)
BICYCLE THERAPEUTICS PLC
Shares:
767016(-39.9%)
Value:
$6.5B(-63.5%)
Beam Therapeutics Inc.
Shares:
315765
Value:
$6.2B
Invivyd, Inc.
Shares:
9722254(-9.0%)
Value:
$5.9B(+24.2%)
Xencor Inc
Shares:
549439(+9.9%)
Value:
$5.8B(-49.1%)
Regulus Therapeutics Inc.
Shares:
3262564(+0.0%)
Value:
$5.7B(+10.8%)
INOVIO PHARMACEUTICALS, INC.
Shares:
3119162(+0.0%)
Value:
$5.1B(-10.9%)
Rapport Therapeutics, Inc.
Shares:
457556
Value:
$4.6B